NEW YORK (GenomeWeb News) - Beckman Coulter today said second-quarter revenues increased 12 percent as R&D spending was down 22 percent and profit grew 56 percent.
 
Total receipts for the three months ended June 30 increased to $689.7 million from $616.3 million year over year.
 
Product-related revenue increased 13 percent to $584.7 million while service-related revenue was up 7 percent to $105 million. Sales of consumables grew 10.3 percent, the company said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.